Faricimab: Two in the Bush Is Proving Better than One in the Hand?
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Francesco Bandello, Baruch D. Kuppermann, Anat Loewenstein
Abstract
The last decade in the treatment of vascular pathologies of the retina has largely been limited to one cytokine: the vascular endothelial growth factor (VEGF) and its interaction with the receptor ...
Topics & Concepts
MedicineVascular endothelial growth factorVEGF receptorsOphthalmologyCytokineImmunologyInternal medicineRetinal Diseases and TreatmentsRetinal and Optic ConditionsOcular Diseases and Behçet’s Syndrome